Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 6, 2011, Pages 2279-2284

  Picchi, Andrea ^a   Limbruno, Ugo ^a   Focardi, Marta ^a   Cortese, Bernardo ^a   Micheli, Andrea ^a   Boschi, Letizia ^b   Severi, Silva ^a   de Caterina, Raffaele ^c  

^a MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Insulin resistance; Microcirculation; Microcirculatory dysfunction; Myocardial blood flow

Indexed keywords

ADENOSINE;

ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIABETES MELLITUS; FRACTIONAL FLOW RESERVE; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; INDEX OF MICROVASCULAR RESISTENCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; TIME; TRANSIT TIME;

ADENOSINE; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DIABETIC ANGIOPATHIES; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; INSULIN RESISTANCE; ITALY; LINEAR MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; THERMODILUTION; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 82855167272     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00615.2011     Document Type: Article

References (42)

1. Aarnoudse W, Fearon WF, Manoharan G, Geven M, van de Vosse F, Rutten M, De Bruyne B, Pijls NH. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 110: 2137-2142, 2004.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 34, Suppl 1: S62-S69, 2011.
3. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow and agonist-induced dilations of coronary arterioles in type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 285: H1404-H1410, 2003.
4. Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K. Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol 280: H977-H983, 2001.
5. Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med 50: 1076-1087, 2009.
6. Chatham JC, Seymour AM. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55: 104-112, 2002.
7. de Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, Gould KL, Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation 104: 2401-2406, 2001.
8. de Bruyne B, Pijls NH, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: experimental validation. Circulation 104: 2003-2006, 2001.
9. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42: 328-335, 2003.
10. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 88: 1009-1086, 2008.
11. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation 107: 3129-3132, 2003.
12. Fearon WF, Farouque HM, Balsam LB, Caffarelli AD, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG. Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Circulation 108: 2198-2200, 2003.
13. Fokkema DS, VanTeeffelen JW, Dekker S, Vergroesen I, Reitsma JB, Spaan JA. Diastolic time fraction as a determinant of subendocardial perfusion. Am J Physiol Heart Circ Physiol 288: H2450-H2456, 2005.
14. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42: 678-687, 1999.
15. Knaapen P, Camici PG, Marques KM, Nijveldt R, Bax JJ, Westerhof N, Gotte MJ, Jerosch-Herold M, Schelbert HR, Lammertsma AA, van Rossum AC. Coronary microvascular resistance: methods for its quantification in humans. Basic Res Cardiol 104: 485-498, 2009.
16. Lee JC, Downing SE. Coronary dynamics and myocardial metabolism in the diabetic newborn lamb. Am J Physiol Heart Circ Physiol 237: H118-H124, 1979.
17. MacCarthy P, Berger A, Manoharan G, Bartunek J, Barbato E, Wijns W, Heyndrickx GR, Pijls NH, De Bruyne B. Pressure-derived measurement of coronary flow reserve. J Am Coll Cardiol 45: 216-220, 2005.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
19. Melikian N, Kearney MT, Thomas MR, De Bruyne B, Shah AM, MacCarthy PA. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve. Eur Heart J 28: 2188-2194, 2007.
20. Meyer C, Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80: 94A-101A, 1997.
21. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91: 635-640, 1995.
22. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42: 1017-1025, 1993.
23. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99: 69-77, 2006.
24. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334: 1703-1708, 1996.
25. Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, Bech GJ, van de Vosse F. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 105: 2482-2486, 2002.
26. Pitkanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, Lehtimaki TJ, Laine HK, Takala T, Viikari JS, Knuuti J. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47: 248-254, 1998.
27. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110: 803-809, 2004.
28. Rossen JD, Winniford MD. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans. J Am Coll Cardiol 21: 343-348, 1993.
29. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107: 3040-3046, 2003.
30. Shivu GN, Phan TT, Abozguia K, Ahmed I, Wagenmakers A, Henning A, Narendran P, Stevens M, Frenneaux M. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation 121: 1209-1215, 2010.
31. Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes 51: 1110-1117, 2002.
32. Standen NBQJ. K-channel modulation in arterial smooth muscle. Acta Physiol Scand 164: 549-558, 1998.
33. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
34. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes 105: 15-20, 1997.
35. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 105: 1727-1733, 2002.
36. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol 49: 839-848, 2007.
37. Tune JD, Yeh C, Setty S, Zong P, Downey HF. Coronary blood flow control is impaired at rest and during exercise in conscious diabetic dogs. Basic Res Cardiol 97: 248-257, 2002.
38. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, Omata M. Reduced myocardial flow reserve in non-insulindependent diabetes mellitus. J Am Coll Cardiol 30: 1472-1477, 1997.
39. Yokoyama I, Yonekura K, Ohtake T, Yang W, Shin WS, Yamada N, Ohtomo K, Nagai R. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. J Nucl Med 41: 978-985, 2000.
40. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105: 1861-1870, 2002.
41. Zucchi R, Limbruno U, Poddighe R, Mariani M, Ronca G. The adenosine hypothesis revisited: relationship between purine release and coronary flow in isolated rat heart. Cardiovasc Res 23: 125-131, 1989.
42. Zucchi R, Limbruno U, Poddighe R, Mariani M, Ronca G. Purine release from isolated rat heart: a new approach to the study of energy metabolism. J Mol Cell Cardiol 22: 815-826, 1990